1) cervical squamous cell carcinoma
子宫颈鳞状细胞癌
1.
Studies on relationship between epstein-barr virus (EBV) latent in fection and cervical squamous cell carcinoma;
EB病毒感染与子宫颈鳞状细胞癌相关性的研究
2.
Objective To explore the relationship between human papillomavirus(HPV)16 infection and the expression of p33ING1b,human telomerase reverse transcriptase(hTERT) in cervical squamous cell carcinoma of Uygur Female in Xinjiang Uygur Autonomous Region.
目的探讨新疆维吾尔族妇女子宫颈鳞状细胞癌组织中人乳头瘤病毒(HPV)16感染和p33ING1b及端粒酶逆转录酶催化亚单位(hTERT)表达的相关性。
3) cervical squamous cell carcinoma
宫颈鳞状细胞癌
1.
6%in cervical squamous cell carcinoma,were 92.
方法采用SP法检测宫颈鳞状细胞癌、宫颈上皮内瘤变(CIN)、尖锐湿疣及正常宫颈组织中p16INK4A、p53、Ki-67及ER蛋白的表达。
2.
Aim: To detect the expression of Survivin, Fas and FasL in cervical squamous cell carcinoma(SCC) tissue.
目的检测宫颈鳞状细胞癌(SCC)组织中Survivin、Fas及FasL蛋白的表达。
3.
ObjectiveTo investigate the expressions of CyclinD1 and P27 proteins in cervical squamous cell carcinoma,and discuss the relationship between their expressions and tumor s clinical and pathological characters.
目的研究CyclinD1和P27蛋白在宫颈鳞状细胞癌发生、发展中的作用及其与宫颈鳞癌临床病理特征的关系。
4) cervical squamous carcinoma
宫颈鳞状细胞癌
1.
Expression and significance of PTEN and PCNA in cervical squamous carcinoma tissue;
宫颈鳞状细胞癌组织中PTEN、PCNA的表达及意义
2.
Objective To investigate the correlation between the expressions of Cyclin D1,Ki-67 and clinical pathological features in cervical squamous carcinoma.
目的探索细胞周期蛋白Cyclin D1和细胞增殖活性标记物Ki-67在宫颈鳞状细胞癌中的表达及其与临床病理特征的相关性。
5) cervical squamous cancer
宫颈鳞状细胞癌
1.
Methods60 samples from patients with pathologically diagnosed as cervical squamous cancer were collected.
结果60例宫颈鳞状细胞癌患者放疗后CR:36例,占60。
6) Cervix squamous cell carcinoma
宫颈鳞状细胞癌
1.
Expression and significance of PAR-1 mRNA in cervix squamous cell carcinoma;
宫颈鳞状细胞癌组织PAR-1基因mRNA的表达及临床意义
补充资料：子宫颈浸润癌
子宫颈浸润癌
本病的病理特点是癌细胞突破基底膜向间质浸润，其深度超过基底膜下3mm，并向周围组织水平扩散＞7mm，常伴淋巴转移。临床分期自Ⅰb期至Ⅳ期。(详见“宫颈癌临床分期”)。子宫颈浸润癌以鳞状细胞癌为最常见，占90%～95%，其次是腺癌，鳞腺癌及其他癌少见。处理见子宫颈鳞状细胞癌及子宫颈腺癌。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条